Published on 25/06/2015

Societe Generale sells 7.04% of Sopra Steria Group's share capital

Societe Generale announces the sale of 7.04% of Sopra Steria Group’s share capital held through its 100% owned subsidiary Geninfo.

Pursuing its disinvestment strategy from industrial holdings, Societe Generale Group will no longer hold any stake in Sopra Steria Group after the transaction.

The sale of shares will be offered in a private placement to be executed by way of an accelerated bookbuilding.

Geninfo received from Sopra GMT (Pasquier and Odin families and the historical Managers), holding on 06/22/2015, 16.4% of the share capital and 25.3% of the voting rights in Sopra Steria Group, an interest to place an order for a maximum of 3.4% of Sopra Steria Group’s share capital for a price equal to the placement price.

Geninfo also received from Sopra Steria Group an interest to place an order for a maximum of 1.5% of Sopra Steria Group’s share capital for a price equal to the placement price, in the context of its share buyback program in order to potentially award or sell shares to employees and/or company officers.

This transaction has been presented to the Autorité des Marchés Financiers (AMF) in accordance with article 234-7 from the “Règlement Général”. During its June 23, 2015 session, the AMF noted that this transaction will not entail the filing of a mandatory takeover bid.

Following the full disposal of Geninfo stake in Sopra Steria Group, Geninfo, Sopra GMT and the founders will no longer act in concert and the shareholders’ agreement will be terminated, not affecting the existing concert on Axway.

The bookbuilding will commence immediately and will be managed by Societe Generale Corporate & Investment Banking, Sole Bookrunner on the transaction.



This announcement is for information purposes only and does not constitute an offer to sell or a solicitation to buy any securities, and the offer of Sopra Steria Group shares by [Societe Generale through its subsidiary Genfino] does not constitute a public offering in any jurisdiction, including in France.

This communication is for distribution in the United Kingdom only to (i) investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (ii) high net worth entities and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons").

The offer and sale of the securities referred to in this announcement has not been, nor will be, registered under the United States Securities Act of 1933 (the "Securities Act") and the securities may not be offered or sold in the United States absent such registration or an applicable exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States in connection with this transaction.

Any investment decision to buy shares in Sopra Steria Group must be made solely on the basis of publicly available information regarding Sopra Steria Group. Such information is not the responsibility of Societe Generale or Geninfo.

Release, publication or distribution of this press release is forbidden in any country where it would violate applicable laws or regulations